KCAT19 T cells News - LARVOL Sigma

||||||||||  KCAT19 T cells / University College London, obecabtagene autoleucel (AUTO1) / Autolus
New P1 trial, Metastases:  KCAT19: Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies (clinicaltrials.gov) -  May 26, 2022
P1, N=12, Not yet recruiting,  Sponsor: University College, London



	Diseases Companies Products Productz Mechanisms of Action Sites